Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma-Reference-Cited by-同舟云学术

Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma

Published:2019-08-27 Issue:50 Volume:10 Page:5136-5151
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

de Pádua Covas Lage Luís Alberto¹,Levy Débora²,Xavier Flávia Dias³,Reis Diego Cândido⁴,de Oliveira Costa Renata⁵,Gonçalves Marianne Castro⁶,Rocha Vanderson¹⁷,Zerbini Maria Cláudia Nogueira⁶,Pereira Juliana¹

Affiliation:

1. Department of Hematology, Hemotherapy and Cell Therapy, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil

2. Laboratory of Medical Investigation in Genetics and Molecular Hematology (LIM-31), Universidade de São Paulo, SãoPaulo, Brazil

3. Department of Hematology and Hemotherapy, Faculdade de Medicina da Universidade de Brasília, Brasília, Brazil

4. Medical Sciences Discipline, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

5. Department of Hematology and Hemotherapy Discipline, Faculdade de Ciências Médicas de Santos/Centro Universitário Lusíada, Santos, Brazil

6. Departamento of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

7. President Fundação Pró-Sangue, Churchill Hospital, Oxford University, Oxford, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local Wisdom and Conservation of Protected Forest in Aceh, Indonesia: Myth as Surveillance of Action;Journal of Law and Sustainable Development;2023-10-04

2. Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas;Clinical Epigenetics;2022-12

3. Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen–Results of a Real-Life Study From a Middle-Income Country;Clinical Lymphoma Myeloma and Leukemia;2022-11

4. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients;Cancer Biomarkers;2022-10-12

5. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort;Leukemia Research;2022-03